A webinar exploring the benefits and uses of the UK’s only licensed product to control clinical signs associated with the bone resorptive processes of navicular syndrome in horses, will be held later this month.
The free interactive webinar, titled “Vets Talk Osphos” takes place on March 25 at 7:30pm.
The keynote speaker will be Alana McGlade, a graduate of Nottingham Veterinary School who worked in equine practice before moving into the veterinary pharmaceutical industry.
A keen equestrian, Alana uses her wealth of equine knowledge in her role as Dechra’s technical equine sales manager.
The webinar will cover Clodronic acid and bisphosphonates, how Osphos works, the key benefits and how to administer it, its efficacy and repeat treatments. It will be followed by a question and answer session.
Emma Jennings, brand manager at Dechra Veterinary Products, said: “Osphos is a key treatment in our equine portfolio and the webinar aims to update vets on how it can benefit them in practice.”
- To register for the webinar, please visit www.dechra.co.uk/webinar